The pharmacological profile of GHK-Cu observed in preclinical models covers a broad spectrum of activity: Stimulation of extracellular matrix synthesis influence on the production of collagen, elastin and glycosaminoglycans in dermal fibroblasts Pro-regenerative and pro-angiogenic effects in in vivo and in vitro wound healing models Modulation of gene expression in transcriptomic studies, the impact on hundreds of tissue repair and antioxidant defense genes Transport of copper ions GHK as a physiological carrier of Cu, a cofactor of matrix enzymes Antioxidant and anti-inflammatory activity reduction of oxidative stress markers in cell models GHK-Cu is a model ligand for testing in the group of plasma peptides connective tissue remodeling and copper biology combines a signaling function with trace element transport, making it a tool for studying the interface between copper metabolism and extracellular matrix repair

Report illegal sales or websites selling unlicensed medicines via the MHRA's dedicated enforcement reporting portal (gov.uk/report-problem-medicine-medical-device)
Clinical studies on lipotropic injections show modest improvements in energy, stamina, and fat mobilization when combined with lifestyle modification
The product on this page is a research-grade lyophilized peptide vial covered by HPLC, LC-MS, amidation, and endotoxin documentation for in vitro laboratory work, with no patient-directed preparation, prescription pathway, or pharmacy dispensing involved in the supply workflow